Extraordinary claims require extraordinary evidence
- 30 September 2005
- journal article
- editorial
- Published by Elsevier in Journal of Health Economics
- Vol. 24 (5) , 1034-1044
- https://doi.org/10.1016/j.jhealeco.2005.07.002
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Extraordinary claims require extraordinary evidenceJournal of Health Economics, 2005
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Returns on Research and Development for 1990s New Drug IntroductionsPharmacoEconomics, 2002
- New drug development in the United States from 1963 to 1999Clinical Pharmacology & Therapeutics, 2001
- Longer Patents for Increased Generic Competition in the USPharmacoEconomics, 1996
- New drug development in the United States from 1963 to 1992Clinical Pharmacology & Therapeutics, 1994
- Returns to R&D on new drug introductions in the 1980sJournal of Health Economics, 1994
- New drug development in the United States from 1963 to 1990Clinical Pharmacology & Therapeutics, 1991
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- A New Look at the Returns and Risks to Pharmaceutical R&DManagement Science, 1990